Skip to main content

Handouts

General Session: Government Enforcement Panel

Presentation
Evaluation

101 Anti-Kickback Statute Case Studies and OIG’s Regulatory Flexibilities During the COVID-19 Pandemic

Presentation
Evaluation

102 False Claims Act Liability in Post-Acute Care

Presentation
Evaluation

103 Preventing Enforcement Actions in Clinical Research: Operational Strategies for Avoiding Financial Frauds

Presentation
Evaluation

201 Managed Care Enforcement and Compliance

Presentation
Evaluation

202 How OIG Uses Data in its Affirmative Cases & How Data Can be Incorporated into Compliance

Presentation
Evaluation

203 The Myth(s) of Median to 75th: New Perspectives on Assessing, Managing and Monitoring Physician Compensation Arrangement Risk

Presentation
Evaluation

General Session: Whistleblowers: Who Are They, Why Do They Bring Cases, and What Makes a Good Whistleblower Case

Presentation
Evaluation

301 Federal Administrative Sanctions

Presentation
Evaluation

302 DOJ Updated Guidance: June 2020

Presentation
Evaluation

303 Lessons Learned from Stark Investigations

Presentation
Evaluation

401 Enforcement and Compliance for Pharmacies

Presentation
Evaluation

402 Why Whistleblowers Matter to Healthcare Compliance

Presentation
Handout 1
Handout 2
Handout 3
Evaluation

403 Trends and Best Practices in Healthcare Privacy and Security Investigations

Presentation
Handout 1
Handout 2
Handout 3
Handout 4
Handout 5
Handout 6
Evaluation

501 Self-Disclosure Protocol

Presentation
Evaluation

502 The Secret Sauce for Complying with Privacy Regulations

Presentation
Evaluation

503 Encryption: Policy to Practice, Lower Risk, Increase Compliance

Presentation
Evaluation

 

General Session: CMS Update

Presentation
Evaluation

601 Negotiating CIAs: What’s New, What’s Different, What Do You Need to Know?

Presentation
Evaluation

602 Civil and Criminal Telehealth Enforcement Matters; DME, Pharmaceutical and Other Covered Items and Services

Presentation
Evaluation

603 Understanding and Preserving Privilege During Compliance Investigations

Presentation
Evaluation

701 Laboratory Enforcement and Compliance

Presentation
Evaluation

702 340 B Compliance

Presentation
Evaluation

703 Three Competing Perspectives on Federal Healthcare Enforcement Trends: Federal Prosecutor, InHouse Counsel, Outside Counsel

Presentation
Evaluation

General Session: DOJ’s Consumer Protection Branch: Safeguarding Americans from Dangerous Drugs and Devices

Presentation
Evaluation

801 Get ‘Em Where it Hurts: Using Compensation to Influence Compliance

Presentation
Evaluation

802 Enforcement and Compliance Risks Associated with the Opioid Crisis: Who's to Blame Will Cast a Wide Net

Presentation
Evaluation

803 Ask the Stark Professionals

Presentation
Evaluation

901 CMS Oversight and Enforcement of Safety and Quality Standards

Presentation
Evaluation

902 Big Data: How Can It Be Shared and What Are the Considerations Regarding Enforcement?

Presentation
Evaluation

903 Hot OIG Target Area: Device Reporting & Related Outlier

Presentation
Evaluation

 

W1 Compliance, Internal Investigations and Self Disclosure: Building the Team, Process, and Resolution

Presentation
Evaluation

W2 Medical Necessity and Civil and Criminal Liability

Presentation
Evaluation

W3 Electronic Health Records Fraud Enforcement: What, Why, and Thoughts for Compliance Professionals

Presentation
Evaluation

W4 Negotiating and Mediating False Claims Act Cases

Presentation
Evaluation

W5 Compliance Officers, General Counsel and Enforcement

Presentation
Evaluation

W6 Data Analytics and AI to Detect and Defend Fraud

Presentation
Evaluation

W7 Anatomy of a False Claims Act Case

Presentation
Evaluation

W8 Medicaid Fraud Enforcement Update

Presentation
Evaluation

W9 Litigating a False Claims Act Case

Presentation
Evaluation

W10 CIAs and IROs: What Are They and Why Do They Matter?

Presentation
Handout 1
Handout 2
Handout 3
Evaluation

W11 Is your Conflicts of Interest Program Effective?

Presentation
Evaluation

W12 Understanding the Components of a Comprehensive Compliance Risk Assessment Process

Presentation
Evaluation

W13 Strategies and Best Practices for Responding to Enforcement Activities

Presentation
Handout 1
Handout 2
Handout 3
Evaluation

W14 Handling a Criminal Healthcare Fraud Case

Presentation
Evaluation

W15 Root Cause Analysis Workshop

Presentation
Handout 1
Handout 2
Evaluation